Kyverna Therapeutics Names Cell Therapy Expert Tom Van Blarcom, Ph.D., as Senior Vice President, Head of Research
- Tuesday, August 23, 2022, 7:04
- Finance
- Add a comment
Dr. Van Blarcom brings 15 years’ experience as a leader in cell therapy research and scientific operations to advance development of Kyverna’s Treg and CAR T platforms for autoimmunity EMERYVILLE, Calif., Aug. 23, 2022 /PRNewswire/ — Kyverna Therapeutics (“Kyverna”), a cell therapy…
About the Author
adminasapcorp has written 39063 stories on this site.